Through discovery, innovation and collaboration, researchers at the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta are investigating new avenues regarding the metastasis of medulloblastoma as well as safer, more effective methods of treatment for children with brain tumors.
Clinical and Translational Research
- Targeted Therapeutics
- Targeted therapeutics involves the discovery of new drugs (targets) aimed at modifying the inappropriate behavior of cancer cells. Our physicians are currently conducting clinical trials to test identified targeted therapeutics for children with brain tumors.
- Genomic Biomarkers
- Insights into the biology of pediatric brain tumors have led to clinical trials to test identified targeted therapeutics for children.
- Children’s is home to the first Center for Pediatric Nanomedicine in the nation. In conjunction with Emory, Georgia Tech and Morehouse, physicians and engineers will develop targeted, molecular-sized nanoparticles as part of a unique approach to treating pediatric diseases, such as pediatric brain tumors. Nanomedicine has the potential to profoundly improve, if not completely revolutionize, the treatment, care and ultimate cure of childhood diseases and conditions.
- Find a clinical trial
Clinical and Translational Researchers